I think Taimoor164 makes a fair point for exactly the reasons you have mentioned col69. As you have said, the current share price really only reflects the likely sales generated by Ryoncil if/when approved. While I wouldn’t want to see large gaps created by a rapid share price rise due to the recent announcement, I am surprised to see meso trend downwards on the 2nd day post announcement. As a health care practitioner I have a comprehensive understanding of the mechanism of action for mesoblasts stem cell therapies and am 100% certain that the vast majority of mesoblasts therapies will have positive results, however the underlying potential of this stock is not being reflected in the share price and I can see why some are frustrated or confused. I believe this is predominantly due to a general lack of pathophysiological knowledge surrounding stem cell therapy among the vast majority of investors and just using this company as a short term/day trading stock. hoping to see the potential of this stock and it’s treatments publicised more widely to get more investors on-board.
- Forums
- ASX - By Stock
- MSB
- MESO Nasdaq update
MESO Nasdaq update, page-280
-
-
- There are more pages in this discussion • 5,176 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9996 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.5¢ | 18069 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9996 | 0.990 |
2 | 32880 | 0.985 |
4 | 71034 | 0.980 |
2 | 3059 | 0.975 |
7 | 145890 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
0.995 | 1132 | 1 |
1.000 | 9500 | 3 |
1.005 | 35000 | 1 |
1.010 | 58113 | 4 |
1.015 | 46100 | 3 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online